DE60228071D1 - Spiropyrazol-verbindungen - Google Patents

Spiropyrazol-verbindungen

Info

Publication number
DE60228071D1
DE60228071D1 DE60228071T DE60228071T DE60228071D1 DE 60228071 D1 DE60228071 D1 DE 60228071D1 DE 60228071 T DE60228071 T DE 60228071T DE 60228071 T DE60228071 T DE 60228071T DE 60228071 D1 DE60228071 D1 DE 60228071D1
Authority
DE
Germany
Prior art keywords
spiropyrazol
connections
whereinz
compound
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60228071T
Other languages
German (de)
English (en)
Inventor
R Richard Goehring
Donald Kyle
Gary Lee
Parviz Gharagozloo
Sam Victory
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Euro Celtique SA
Original Assignee
Euro Celtique SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique SA filed Critical Euro Celtique SA
Application granted granted Critical
Publication of DE60228071D1 publication Critical patent/DE60228071D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Dental Preparations (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
DE60228071T 2001-04-18 2002-04-18 Spiropyrazol-verbindungen Expired - Lifetime DE60228071D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28467501P 2001-04-18 2001-04-18
PCT/US2002/012376 WO2002085355A1 (en) 2001-04-18 2002-04-18 Spiropyrazole compounds

Publications (1)

Publication Number Publication Date
DE60228071D1 true DE60228071D1 (de) 2008-09-18

Family

ID=23091099

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60228071T Expired - Lifetime DE60228071D1 (de) 2001-04-18 2002-04-18 Spiropyrazol-verbindungen

Country Status (27)

Country Link
US (2) US6635653B2 (enExample)
EP (1) EP1385515B1 (enExample)
JP (1) JP4342181B2 (enExample)
KR (1) KR100628292B1 (enExample)
CN (1) CN1516584A (enExample)
AT (1) ATE403429T1 (enExample)
AU (1) AU2002311833B2 (enExample)
BR (1) BR0209127A (enExample)
CA (1) CA2444634C (enExample)
CY (1) CY1108454T1 (enExample)
CZ (1) CZ20032849A3 (enExample)
DE (1) DE60228071D1 (enExample)
DK (1) DK1385515T3 (enExample)
ES (1) ES2312584T3 (enExample)
HU (1) HUP0401333A3 (enExample)
IL (2) IL158485A0 (enExample)
MX (1) MXPA03009604A (enExample)
NO (1) NO20034660L (enExample)
NZ (1) NZ528978A (enExample)
PL (1) PL367263A1 (enExample)
PT (1) PT1385515E (enExample)
RU (1) RU2299883C2 (enExample)
SI (1) SI1385515T1 (enExample)
UA (1) UA74439C2 (enExample)
WO (1) WO2002085355A1 (enExample)
YU (1) YU82403A (enExample)
ZA (1) ZA200308103B (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA74439C2 (uk) * 2001-04-18 2005-12-15 Еро-Селтік, С.А. Сполуки спіропіразолу
US7566728B2 (en) * 2002-03-29 2009-07-28 Mitsubishi Tanabe Pharma Corporation Remedy for sleep disturbance
EA009369B1 (ru) 2002-09-09 2007-12-28 Янссен Фармацевтика, Н.В. Производные гидроксизамещенного 1,3,8-триазинспиро[4,5]декан-4-она, полезные для лечения расстройств, опосредованных orl-рецептором
EP1551400A2 (en) * 2002-10-17 2005-07-13 Euro-Celtique S.A. Preparation of triazospiro compounds
US20040242583A1 (en) * 2003-01-20 2004-12-02 Aventis Pharma Deutschland Gmbh Pyrimido[5,4-e][1,2,4]triazine-5,7-diones, processes for preparing them and their use
WO2004103305A2 (en) * 2003-05-16 2004-12-02 Euroceltique S.A. Spiropyrazole compound
WO2005011665A1 (en) * 2003-07-22 2005-02-10 Arakis Ltd. The use of proglumide for the treatment of emesis
US20110008327A1 (en) * 2004-03-29 2011-01-13 Cheng Jin Q Compositions including triciribine and epidermal growth factor receptor inhibitor compounds or salts thereof and methods of use thereof
WO2005094322A2 (en) 2004-03-29 2005-10-13 University Of South Florida Effective treatment of tumors and cancer with triciribine and related compounds
US20100028339A1 (en) 2004-03-29 2010-02-04 Cheng Jin Q Compositions including triciribine and trastuzumab and methods of use thereof
US20100173864A1 (en) * 2004-03-29 2010-07-08 Cheng Jin Q Compositions including triciribine and one or more platinum compounds and methods of use thereof
US20100009929A1 (en) 2004-03-29 2010-01-14 Cheng Jin Q Compositions including triciribine and bortezomib and derivatives thereof and methods of use thereof
US20100009928A1 (en) 2004-03-29 2010-01-14 Cheng Jin Q Compositions including triciribine and taxanes and methods of use thereof
NZ556628A (en) 2005-03-08 2009-09-25 Janssen Pharmaceutica Nv Diaza-spiro-[4.4]-nonane derivatives as neurokinin (NK1) antagonists
CN1870631B (zh) * 2005-11-11 2010-04-14 华为技术有限公司 媒体网关的门控方法
US20080051380A1 (en) 2006-08-25 2008-02-28 Auerbach Alan H Methods and compositions for treating cancer
MX2009005641A (es) 2006-11-28 2009-06-05 Janssen Pharmaceutica Nv Sales de 3-(3-amino-2-(r)-hidroxi-propil)-1-(4-fluoro-fenil)-8-(8- metil-naftalen-1-ilmetil)-1,3,8-triaza-espiro[4,5]deca n-4-ona.
CA2675419C (en) * 2007-01-16 2013-11-12 Purdue Pharma L.P. Heterocyclic-substituted piperidine compounds and the uses thereof
CN101679430B (zh) 2007-04-09 2013-12-25 詹森药业有限公司 用于治疗焦虑和抑郁症的作为orl-1受体的配体的1,3,8-三取代-1,3,8-三氮杂-螺[4.5]癸-4-酮衍生物
KR20120102172A (ko) 2007-08-31 2012-09-17 시오노기세이야쿠가부시키가이샤 치환-퀴녹살린-형 피페리딘 화합물 및 그의 용도
BRPI0911031B8 (pt) 2008-07-21 2021-05-25 Purdue Pharma Lp compostos de piperidina ligada do tipo quinoxalina substituídos e os usos destes
UA107943C2 (xx) * 2009-11-16 2015-03-10 Lilly Co Eli Сполуки спіропіперидину як антагоністи рецептора orl-1
US9598447B2 (en) 2010-12-22 2017-03-21 Purdue Pharma L.P. Phosphorus-substituted quinoxaline-type piperidine compounds and uses thereof
WO2013080036A1 (en) 2011-12-01 2013-06-06 Purdue Pharma L.P. Azetidine-substituted quinoxaline-type piperidine compounds and uses thereof
US9085561B2 (en) 2012-07-30 2015-07-21 Purdue Pharma L.P. Cyclic urea- or lactam-substituted quinoxaline-type piperidines as ORL-1 modulators
US9951038B2 (en) 2012-12-27 2018-04-24 Purdue Pharma L.P. Quinazolin-4(3H)-one-type piperidine compounds and uses thereof
US9040533B2 (en) 2012-12-27 2015-05-26 Purdue Pharma L.P. Oxime-substituted-quinoxaline-type piperidine compounds as ORL-1 modulators
US10118927B2 (en) 2012-12-27 2018-11-06 Purdue Pharma L.P. Substituted piperidin-4-amino-type compounds and uses thereof
WO2014102594A2 (en) 2012-12-27 2014-07-03 Purdue Pharma L.P. Substituted benzimidazole-type piperidine compounds and uses thereof
US9963458B2 (en) 2012-12-27 2018-05-08 Purdue Pharma L.P. Indole and indoline-type piperidine compounds and uses thereof
WO2018023017A1 (en) 2016-07-29 2018-02-01 Janssen Pharmaceutica Nv Methods of treating prostate cancer
CN111825681A (zh) * 2020-07-07 2020-10-27 扬州大学 一种合成(e)-亚苄基螺吡唑吡咯嗪酮类化合物的方法

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB157497A (enExample) *
US3161645A (en) 1962-12-18 1964-12-15 Res Lab Dr C Janssen N V 1-(1-aroylpropyl-4-piperidyl)-2-benzimidazolinones and related compounds
US3318900A (en) 1964-05-06 1967-05-09 Janssen Pharmaceutica Nv Derivatives of benzimidazolinyl piperidine
US3325499A (en) 1964-11-02 1967-06-13 Mcneilab Inc 1-(1-hydrocarbyl-4-piperdyl)-2-indolinone
US3923993A (en) * 1973-06-28 1975-12-02 American Home Prod Process for treating neuroendocrinopathic diseases employing fluspirilene
DE2609645A1 (de) 1976-03-09 1977-09-15 Boehringer Sohn Ingelheim Aminoalkylheterocyclen
US4329353A (en) 1980-10-22 1982-05-11 Janssen Pharmaceutica, N.V. 1-(4-Aryl-cyclohexyl)piperidine derivatives, method of use thereof and pharmaceutical compositions thereof
US4410528A (en) 1980-05-16 1983-10-18 Kyowa Hakko Kogyo Co., Ltd. Hypotensive piperidine derivatives
JPS58180481A (ja) 1982-04-15 1983-10-21 Kyowa Hakko Kogyo Co Ltd 新規なピペリジン誘導体
JPS60120872A (ja) 1983-12-01 1985-06-28 Kyowa Hakko Kogyo Co Ltd 新規なヘテロ環状化合物及び強心剤
US5534520A (en) * 1990-04-10 1996-07-09 Fisher; Abraham Spiro compounds containing five-membered rings
WO1995028397A1 (en) 1994-04-14 1995-10-26 Merck & Co., Inc. Alpha1c adrenergic receptor antagonists
FR2722190B1 (fr) 1994-07-05 1996-10-04 Sanofi Sa Derives de 1-benzyl-1,3-dihydro-2h-benzimidazol-2-one, leur preparation, les compositions pharmaceutique en contenant
FR2725206B1 (fr) * 1994-09-29 1996-12-06 Roussel Uclaf Nouvelles imidazolidines substituees par un heterocycle, leur procede et des intermediaires de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
US5767118A (en) 1994-10-26 1998-06-16 Merck & Co., Inc. 4-Heterocyclic peperidines promote release of growth hormone
US5574044A (en) 1994-10-27 1996-11-12 Merck & Co., Inc. Muscarine antagonists
DE69621469T2 (de) 1995-09-13 2002-12-12 Kyowa Hakko Kogyo Co., Ltd. Phenylpiperidin-derivate
EP0898568B1 (en) 1996-04-19 2006-10-04 Neurosearch A/S 1-(4-piperidyl)-benzimidazoles having neurotrophic activity
US6063796A (en) 1997-04-04 2000-05-16 Merck & Co., Inc. Somatostatin agonists
EP0990653B1 (en) 1997-05-30 2004-09-15 Banyu Pharmaceutical Co., Ltd. 2-oxoimidazole derivatives
JPH10330377A (ja) 1997-06-02 1998-12-15 Kyowa Hakko Kogyo Co Ltd ピペリジン誘導体
US6166037A (en) 1997-08-28 2000-12-26 Merck & Co., Inc. Pyrrolidine and piperidine modulators of chemokine receptor activity
EP0921125B1 (en) 1997-12-05 2002-01-30 F. Hoffmann-La Roche Ag 1,3,8-Triazaspiro[4,5]decan-4-on derivatives
US6166209A (en) 1997-12-11 2000-12-26 Hoffmann-La Roche Inc. Piperidine derivatives
JP3342478B2 (ja) 1998-01-19 2002-11-11 ファイザー製薬株式会社 Ｏｒｌ１−レセプターアゴニストとしての４−（２−ケト−１−ベンズイミダゾリニル）ピペリジン化合物
NZ507760A (en) 1998-03-26 2002-10-25 Japan Tobacco Inc Amide derivatives and nociceptin antagonists
JP2002515503A (ja) * 1998-05-18 2002-05-28 ノボ ノルディスク アクティーゼルスカブ オピオイド受容体のサブタイプへの高い親和性を有する新規１，３，８−トリアザスピロ〔４，５〕デカノン
ID29137A (id) 1998-07-27 2001-08-02 Schering Corp Ligan-ligan afinitas tinggi untuk reseptor nosiseptin orl-1
US6262066B1 (en) 1998-07-27 2001-07-17 Schering Corporation High affinity ligands for nociceptin receptor ORL-1
MA26659A1 (fr) 1998-08-06 2004-12-20 Pfizer Dérivés de benzimidazole nouveaux, compositions pharmaceutiques les contenant et procédé pour leur préparation.
SE9904652D0 (sv) 1999-12-17 1999-12-17 Astra Pharma Prod Novel Compounds
AU8870601A (en) 2000-09-06 2002-03-22 Ortho Mcneil Pharm Inc A method for treating allergies using substituted pyrazoles
UA74439C2 (uk) * 2001-04-18 2005-12-15 Еро-Селтік, С.А. Сполуки спіропіразолу

Also Published As

Publication number Publication date
IL158485A (en) 2009-09-01
UA74439C2 (uk) 2005-12-15
US20030027834A1 (en) 2003-02-06
CA2444634A1 (en) 2002-10-31
ES2312584T3 (es) 2009-03-01
BR0209127A (pt) 2006-03-21
AU2002311833B2 (en) 2005-04-28
WO2002085355A1 (en) 2002-10-31
MXPA03009604A (es) 2004-04-02
CZ20032849A3 (en) 2004-03-17
US20040087641A1 (en) 2004-05-06
PL367263A1 (en) 2005-02-21
KR20040008159A (ko) 2004-01-28
JP2004531531A (ja) 2004-10-14
JP4342181B2 (ja) 2009-10-14
EP1385515B1 (en) 2008-08-06
RU2003133455A (ru) 2005-05-10
DK1385515T3 (da) 2008-10-27
CN1516584A (zh) 2004-07-28
HUP0401333A2 (hu) 2004-10-28
HK1062885A1 (en) 2004-12-03
KR100628292B1 (ko) 2006-09-27
HUP0401333A3 (en) 2004-11-29
ATE403429T1 (de) 2008-08-15
SI1385515T1 (sl) 2008-12-31
CA2444634C (en) 2011-06-07
PT1385515E (pt) 2008-09-15
NZ528978A (en) 2004-06-25
US6635653B2 (en) 2003-10-21
EP1385515A1 (en) 2004-02-04
RU2299883C2 (ru) 2007-05-27
NO20034660L (no) 2003-12-17
ZA200308103B (en) 2004-10-18
YU82403A (sh) 2006-08-17
CY1108454T1 (el) 2014-04-09
IL158485A0 (en) 2004-05-12
EP1385515A4 (en) 2004-06-30
NO20034660D0 (no) 2003-10-17

Similar Documents

Publication Publication Date Title
DE60228071D1 (de) Spiropyrazol-verbindungen
DE60214392D1 (de) 1,4-disubstituierte benzokondensierte cycloalkyl harnstoffverbindungen
MXPA03009600A (es) Analogos de nociceptina.
DK1385514T3 (da) Spiroinden- og spiroindanforbindelser
CY1113578T1 (el) 2,3-διυδρο-6-νιτροϊμιδαζο 2,1 -b-οξαζολια
NO20041493L (no) Kjemiske forbindelser.
CY1106247T1 (el) Θειοφαινο- και θειαζολοσουλφοναμιδες ως αντινεοπλαστικοι παραγοντες
HRP20030383B1 (hr) Laktamski spoj
WO2003006425A3 (en) Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
TR199801629A2 (xx) Fungisidal 2 -metoksibenzofenonlar.
NO20053246D0 (no) Kondensert 1,3-dihydroimidazol-ringforbindelse.
SE0004245D0 (sv) Novel compounds and their use
DE60228072D1 (de) Benzimidazolon-verbindungen
ATE511352T1 (de) Antimikrobielle zusammensetzungen
MXPA03009602A (es) Analogos de nociceptina.
HRP20080057T3 (en) 9,10-alpha,alpha-oh-taxane analogs and methods for production thereof
SE0103710D0 (sv) Compounds
ATE431328T1 (de) Photopolymerisierbare verbindungen
SV2003000981A (es) Fenil-heterociclil-eteres ref. pcs10973
DK1347984T3 (da) Fremgangsmåde til fremstilling af taxanderivater
DK1177191T3 (da) Substituerede benzimidazoler, fremstilling og anvendelse deraf som midler til bekæmpelse af parasitiske protozoer
DE60102704D1 (de) Trioxepan verbindungen
ATE282611T1 (de) Stolonoxide
CY1115144T1 (el) Παραγωγα του uk-2a
ITRM20010403A1 (it) Generatore privo di emissioni.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition